CL-68
gut metagenome
Development of Gastrointestinal Pathogen Free (GPF) macaques and their implications for macaque models
biological_dosage
Azithromycin 40 mg/kg then 20 mg/kg SID x 4 days; paromomycin 25 mg/kg BID x 10 days; fenbendazole 50 mg/kg SID x 5 days; and enrofloxacin 10 mg/kg SID x 10 days
chem_administration
Azithromycin CHEBI:2955; paromomycin CHEBI:7935; fenbendazole CHEBI:77092; and enrofloxacin CHEBI:35720
collection_date
2019-01-11
days
0
description
Development of Gastrointestinal Pathogen Free (GPF) macaques and their implications for macaque models
env_broad_scale
terrestrial biome ENVO:00000446
env_local_scale
animalhouseENVO:00003040
env_medium
fecesENVO:00002003
geo_loc_name
USA:OR
host
Macaca mulatta
host_subject_id
Rh33921
lat_lon
45.31 N 122.52 W
sample_title
CL-68
seq_methods
Illumina miSeq
BioSampleModel
MIMARKS.survey
BioSampleModel
MIGS/MIMS/MIMARKS.host-associated